An Improved Diagnostic Deep Learning Model for Cervical Lymphadenopathy Characterization.
Authors
Affiliations (3)
Affiliations (3)
- Department of In-Patient Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Control Science and Engineering, Harbin Institute of Technology, Harbin, Heilongjiang, China.
- Department of In-Patient Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Electronic address: [email protected].
Abstract
To validate the diagnostic performance of a B-mode ultrasound-based deep learning (DL) model in distinguishing benign and malignant cervical lymphadenopathy (CLP). A total of 210 CLPs with conclusive pathological results were retrospectively included and separated as training (n = 169) or test cohort (n = 41) randomly at a ratio of 4:1. A DL model integrating convolutional neural network, deformable convolution network and attention mechanism was developed. Three diagnostic models were developed: (a) Model I, CLPs with at least one suspicious B-mode ultrasound feature (ratio of longitudinal to short diameter < 2, irregular margin, hyper-echogenicity, hilus absence, cystic necrosis and calcification) were deemed malignant; (b) Model II: total risk score of B-mode ultrasound features obtained by multivariate logistic regression and (c) Model III: CLPs with positive DL output are deemed malignant. The diagnostic utility of these models was assessed by the area under the receiver operating curve (AUC) and corresponding sensitivity and specificity. Multivariate analysis indicated that DL positive result was the most important factor associated with malignant CLPs [odds ratio (OR) = 39.05, p < 0.001], only followed by hilus absence (OR = 6.01, p = 0.001) in the training cohort. In the test cohort, the AUC of the DL model (0.871) was significantly higher than that in model I (AUC = 0.681, p = 0.04) and model II (AUC = 0.679, p = 0.03), respectively. In addition, model III obtained 93.3% specificity, which was significantly higher than that in model I (40.0%, p = 0.002) and model II (60.0%, p = 0.03), respectively. Although the sensitivity of model I was the highest, it did not show a significant difference compared to that of model III (96.2% vs.80.8%, p = 0.083). B-mode ultrasound-based DL is a potentially robust tool for the differential diagnosis of benign and malignant CLPs.